REVIEW article
Front. Immunol.
Sec. Inflammation
The Regnase Pathway: A Core Axis in Immune Regulation and Inflammatory Disease
Provisionally accepted
- San Raffaele Hospital (IRCCS), Milan, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The Regnase/MCPIP ribonucleases are involved in the regulation of immune homeostasis, by degrading RNA transcripts that encode inflammatory and regulatory proteins. This review highlights their molecular architecture, catalytic mechanisms, and intricate regulatory networks that orchestrate innate and adaptive immunity. This article presents a narrative review of the literature on distinct physiological roles of individual family members and how their dysfunction drives inflammatory, autoimmune, fibrotic, metabolic, and neoplastic disorders across multiple tissues. Although Regnase family members exhibit some functional redundancy, each also possesses distinct, non-overlapping roles. Regnase-1 restrains cytokine production and along with Regnase-2 modulates neuroinflammation. Both Regnase-3 and Regnase-4 possess homeostatic functions although they are also involved in orchestrating interferon and myeloid signaling and contribute to immune regulation and tumor suppression. We also examine emerging therapeutic strategies targeting Regnase activity, including antisense oligonucleotides to enhance Regnase-1 expression, gene-and RNA-based delivery approaches, and selective inhibition of Regnase-1 in T cells to boost cancer immunotherapy. Together, these findings underscore Regnase proteins as central post-transcriptional checkpoints in immunity and highlight their potential as targets for treating autoimmune disease, chronic inflammation, fibrosis, and cancer.
Keywords: cytokinehomeostasis, immune tolerance and inflammation, post-transcriptional regulation, Regnase-1, RNA-Binding Proteins, ZC3H12A/MCPIP1
Received: 16 Dec 2025; Accepted: 10 Feb 2026.
Copyright: © 2026 Muzio, Colombo, Molinaro and Ferrati. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Luca Muzio
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.